The FDA said in a court filing late Friday that it would allow pharmacists to continue making compounded versions of ...
On October 7, a compounding trade group filed a lawsuit challenging the agency's action, saying there was still a shortage of ...
Forty years after the Hatch-Waxman Act created a market for affordable generic versions of prescription medications, ...
The Food and Drug Administration (FDA) on Friday declared shortages of three intravenous drugs produced at a North Carolina ...
The U.S. Food and Drug Administration on Friday agreed to reconsider a decision it made last month to bar drug compounders ...
The agency agreed in court to allow compounding companies to continue producing copycat versions of Lilly’s fast-selling medicines while it reevaluates its recent decision to declare the drugs back in ...
Drug shortages that happen when demand surges can ... as compounded drugs are not FDA-approved and could have inconsistent potency. The FDA has issued warnings about the risks of compounded ...
Hurricane Helene damaged one of the major NC-based manufacturing facilities of IV fluids. What’s being done to help hospitals ...
After securing FDA approval, they produce and sell these drugs to distributors ... would offer GPOs bonus payments from Medicare for taking steps to prevent drug shortages, such as signing longer-term ...
A trade group representing compounding pharmacies sued the FDA for a “reckless and arbitrary” decision to remove Eli Lilly's ...
A drug compounding industry group on Monday sued the U.S. Food and Drug Administration over its decision to take Eli Lilly’s ...
The FDA's drug shortage staff already works with ... Before recently, Finley paid little attention to drug shortages, never imagining that critical drugs such as the carboplatin she relied on ...